Biotia Stock

Biotia is a health tech startup offering AI-based solutions to diagnose and control infectious disease.

Sign up today and learn more about Biotia Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Biotia Stock

Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid and precise infectious disease discovery. Their software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes.

Funding History

December 2019$2.4M
August 2022$8.0M



Chris Mason

Co-founder and CEO

Niamh O'Hara

Board Observer

Brendan Fallis


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: